Skip to main content
Signal8

Plesha Scott M.

SEC insider (Form 3/4/5 filer). CIK 0001726687. CEO and President at Pelthos Therapeutics Inc. (PTHS). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 2, 2025. Located in DURHAM, NC.

Companies Plesha Scott M. has filed insider reports for

  • Pelthos Therapeutics Inc. (PTHS): Director, Officer, CEO and President
Plesha Scott M. profile photo

Plesha Scott M.

CIK: 0001726687

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Pelthos Therapeutics Inc. logo
PTHS

Pelthos Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Pelthos Therapeutics Inc. logo
    PTHS

    Pelthos Therapeutics Inc.

    Jul 2, 2025
    Award
    Direct
    83.7K shares-
  • Pelthos Therapeutics Inc. logo
    PTHS

    Pelthos Therapeutics Inc.

    Jul 2, 2025
    Award

    Restricted Stock Units

    Direct
    83.7K shares-
  • Pelthos Therapeutics Inc. logo
    PTHS

    Pelthos Therapeutics Inc.

    Jul 2, 2025
    Award

    Stock Option

    Direct
    255K shares-

1-3 of 3